Urine proteomics DIA disease sampling detection kit
By designing a urine proteomics DIA disease sampling and detection box, using a temperature display screen and anti-corrosion sampling tube, we ensure that the urine samples remain at 0-8℃ during transportation, solving the problem of sample deterioration and contamination and improving the accuracy of detection and resource utilization efficiency.
Patent Information
- Application Number
- CN202323613363.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-28
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2033-12-28
AI Technical Summary
Urine samples are prone to failure in detection due to temperature instability, pollution or deterioration during transportation. The prior art is difficult to effectively ensure the freshness and quality of the samples, resulting in waste of resources and distortion of detection.
A urine proteomics DIA disease sampling and detection box is designed, including a temperature display screen, a temperature sensor and a recorder, providing an additive-free and anti-corrosion sampling tube, combining a foam layer and a brick refrigeration tank to ensure the sample is in the range of 0-8°C. Transport within to prevent bacterial growth.
Real-time tracking and recording of sample temperature is achieved, sample quality is ensured, resource waste is avoided, and the accuracy and repeatability of urine proteomics detection are improved.
Smart Images

Figure CN221970061U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of proteomics sample storage and transportation devices, in particular to a urine proteomics DIA disease sampling and detection kit. Background Art
[0002] In the research and development of precision medicine, proteomics is widely used in the discovery and identification of biomarkers. With the development of technology, urine proteomics analysis has become one of the most concerned research areas for biomarker discovery. On the one hand, urine contains plasma proteins filtered by the kidneys and proteins secreted by the urinary system. By analyzing the protein composition in urine, we can better understand the changes in human health and disease status. On the other hand, compared with the more stable plasma proteome, the urine proteome can reflect the changes in the body caused by diseases earlier and more sensitively; coupled with the fact that urine is a non-invasive sample, it makes urine one of the ideal samples for disease diagnosis, especially for early detection of biomarkers. Data-independent acquisition (DIA) is a targeted proteomics technology that fragments and analyzes all ions within a selected mass-to-charge ratio range by secondary mass spectrometry. DIA is an alternative to data-dependent acquisition (DDA). Its advantage is that it can efficiently measure protein molecules with extremely low abundance in complex samples and improve the credibility of quantitative analysis. Therefore, using DIA technology for urine sample testing can further improve the accuracy and repeatability of urine proteomics quantitative analysis and help discover new biomarkers and potential therapeutic targets.
[0003] Urine samples need to be stored and transported in a timely and reasonable manner after collection. In order to ensure the freshness of urine samples, they are generally required to be sent for inspection within 2-4 hours. However, many patients are sent to inspection units far away, so they need to be stored and transported at a low temperature of 4-8°C, otherwise it is easy to breed bacteria and affect the detection effect of samples. The existing transportation method is generally transported in foam boxes with ice packs. However, some unstable factors often occur during the sample delivery process, causing urine samples to leak, be contaminated or deteriorate, resulting in samples that cannot be used. Therefore, DIA urine proteomics testing agencies often need to communicate closely with sample providers before obtaining urine samples to ensure that the sampling process and transportation conditions are in compliance with the specifications. However, due to the information gap in communication and the instability of actual transportation conditions, the testing agency often receives urine samples that do not meet the requirements. Although some samples can be observed to be deteriorated by the naked eye, they can be discarded, re-collected and transported; but some inferior samples cannot be identified by the naked eye. If proteomics testing continues, distorted data with no reference significance will be obtained, and human and material resources will be greatly wasted in the process. Utility Model Content
[0004] The purpose of the utility model is to provide a urine proteomics DIA disease sampling and detection kit to address the deficiencies of the prior art and solve the problems in the above-mentioned background technology.
[0005] To achieve this purpose, the technical solution adopted by the utility model is: a urine proteomics DIA disease sampling and detection kit, including a packaging box, a cold storage room, a storage room, and a temperature display screen, wherein the temperature display screen is placed outside the packaging box, and the cold storage room and the storage room are placed inside the packaging box, and a temperature sensor and a recorder are arranged inside the temperature display screen, and the temperature sensor is electrically connected to the recorder on the inner side of the temperature display screen; the storage room is arranged at the top of the packaging box, and the DIA kit instruction manual, urine cup, sealing bag, non-additive sampling tube and antiseptic sampling tube are placed in the storage room; the cold storage room is arranged at the bottom of the packaging box, and a foam layer is arranged around the cold storage room, a cold storage tank is embedded in the foam layer, the outer wall of the cold storage tank is provided with a thermal insulation coating, and ice bricks are embedded in the cold storage tank.
[0006] Furthermore, the storage chamber is located directly above the refrigerated tank, and the storage chamber is embedded in the foam layer until the top of the storage chamber is flush with the top of the foam layer.
[0007] Furthermore, the non-additive sampling tube is loaded with urine samples for transportation within 0-8 hours, and the antiseptic sampling tube is loaded with urine samples for transportation within 8-24 hours.
[0008] Furthermore, a water-soluble bagged preservative is provided in the antiseptic sampling tube, and the preservative is any one of toluene or boric acid.
[0009] Furthermore, the water-soluble outer packaging bag of the preservative is made of polyvinyl alcohol.
[0010] Furthermore, the ice bricks are filled with refrigeration liquid, and the ice bricks can be disassembled at any time for freezing and reuse.
[0011] Furthermore, a socket groove is fixed on the inner wall of the refrigeration tank 9, and an ice brick 11, an anti-corrosion sampling tube 7 or a non-additive sampling tube 6 is embedded in the socket groove.
[0012] Furthermore, the temperature in the refrigerated tank is maintained at 0-8°C.
[0013] The utility model has the advantages that:
[0014] 1. The utility model urine proteomics DIA disease sampling and detection kit is equipped with a temperature display screen, a temperature sensor and a recorder, which can realize real-time tracking and recording of temperature, evaluate the quality of samples before testing, and then decide whether to enter the testing process. To a certain extent, it can well control the sample quality and save manpower and material resources.
[0015] 2. The urine proteomics DIA disease sampling and detection kit of the utility model is provided with special non-additive sampling tubes and antiseptic sampling tubes for urine samples, which can be selected as needed for urine samples with different transportation times, and can ensure the quality of urine samples to a certain extent, avoid bacterial growth in urine samples, and affect the detection effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 It is a structural schematic diagram of the utility model urine proteomics DIA disease sampling and detection kit.
[0017] Figure 2 It is a top view of the cross section of the temperature display area of the DIA disease sampling and detection kit of the present invention.
[0018] Figure 3 It is a top view of the internal structure of the refrigeration tank of the utility model.
[0019] Figure 4 It is a cross-sectional view of the utility model urine proteomics DIA disease sampling and detection kit.
[0020] The description of the accompanying drawings is as follows: packaging box 1, cold storage room 2, storage room 3, temperature display screen 4, temperature sensor 41, recorder 5, non-additive sampling tube 6, antiseptic sampling tube 7, water-soluble bagged preservative 71, foam layer 8, refrigeration tank 9, refrigeration cover 91, thermal insulation coating 10, ice brick 11. DETAILED DESCRIPTION
[0021] The technical solution described in the utility model will be clearly and completely described below in conjunction with the accompanying drawings of the utility model. Obviously, the implementation methods described in this specification are only part of the feasible technical solutions of the utility model. Other implementation methods obtained by ordinary technicians in this field based on the specific implementation methods of the utility model without any creative work should be deemed to belong to the scope of protection of the utility model.
[0022] See also Figure 1-4, a urine proteomics DIA disease sampling and detection kit, comprising a packaging box 1, a cold storage room 2, a storage room 3, and a temperature display screen 4. Among them, the temperature display screen 4 is placed outside the packaging box 1, and the cold storage room 2 and the storage room 3 are placed inside the packaging box 1. A temperature sensor 41 and a recorder 5 are arranged inside the temperature display screen 4, and the temperature sensor 41 is electrically connected to the recorder 5 on the inner side of the temperature display screen 4. The utility model device monitors the ambient temperature inside the urine proteomics DIA disease sampling and detection kit in real time through the temperature sensor 41, and the temperature will be intuitively displayed on the temperature display screen 4; subsequently, through the combination between the temperature sensor 41 and the recorder 5, real-time tracking and recording of the temperature can be achieved; subsequently, after the party to be tested receives the DIA disease sampling and detection kit containing the urine sample, the temperature monitoring record can be called up to evaluate the quality of the sample, to determine whether the sample has been in an environment above 8°C for a long time, and then decide whether to enter the detection process. It can well control the sample quality to a certain extent, saving manpower and material resources.
[0023] The top of the packaging box 1 of the utility model is provided with a storage chamber 3, and the storage chamber 3 contains the instruction manual of the DIA kit, a urine cup, a sealed bag, a non-additive sampling tube 6 and an antiseptic sampling tube 7. The instruction manual of the DIA kit of the utility model includes a series of detailed introductions such as the assembly and disassembly of the DIA kit, the use of the cold storage room and internal components, the collection and loading of urine samples, the selection of sampling tubes and the requirements for transportation conditions, and the flexible use of the urine proteomics DIA disease sampling detection kit can be achieved according to the corresponding instructions.
[0024] A refrigerating chamber 2 is provided at the bottom of the packaging box 1 of the utility model, and a foam layer 8 is provided around the refrigerating chamber 2. The interior of the foam layer is a hollow structure, and a refrigerating tank 9 is embedded in the middle. A storage chamber 3 is embedded above the refrigerating tank 9. At this time, the storage chamber 3 is still embedded in the foam layer 8 until the top of the storage chamber 3 is flush with the top of the foam layer 8.
[0025] The outer wall of the cold storage tank 9 of the utility model is provided with a heat preservation coating 10 around, and a socket groove is fixed on the inner wall of the cold storage tank 9, and an ice brick 11, an antiseptic sampling tube 7 or a non-additive sampling tube 6 are embedded in the socket groove. In addition, the ice brick 11 is filled with a refrigeration liquid. After the patient receives the urine proteomics DIA disease sampling and detection kit, the ice brick can be disassembled at any time for freezing, and after the sampling is completed, it can be installed; then the sampling tube is installed into the socket in the cold storage tank 9, and the cold storage cover 91 is covered; finally, the storage chamber 3 is placed on the top.
[0026] Specifically, the thermal insulation coating 10 of the utility model is made of one of perlite, vitrified microbeads, extruded board XPS or rigid polyurethane foam; through the cooperation of ice bricks 11, thermal insulation coating 10 and foam layer 8, it is more conducive to maintaining the low temperature (0-8°C) of the refrigeration tank 9, so that the urine sample is in a good transportation environment. In addition, the method of taking and loading urine samples of the utility model is: first clean the skin, use a urine cup to collect the sample, and then use the urine cup to pour the urine into the non-additive sampling tube 6 or the antiseptic sampling tube 7, and pour half of the capacity of the sampling tube (25mL); then tighten the sampling tube, install the sampling tube into the jack of the refrigeration tank 9, and put the urine cup into a sealed bag and discard it. In addition, it should be noted that the temperature in the cold storage room needs to be maintained at 0-8°C.
[0027] The sampling tube of the utility model is divided into two types, including a non-additive sampling tube 6 and an anti-corrosion sampling tube 7; wherein, the non-additive sampling tube 6 is suitable for loading urine samples that need to be transported for 0-8 hours, and the anti-corrosion sampling tube 7 is suitable for loading urine samples that need to be transported for 8-24 hours. Patients can evaluate the transportation time of urine samples to the testing agency according to their own environment, and then choose the type of sampling tube based on this. It can ensure the quality of urine samples to a certain extent, avoid bacterial growth in urine samples, and affect the detection effect.
[0028] The utility model antiseptic sampling tube 7 is provided with a water-soluble bagged preservative 71, and the preservative is any one of toluene or boric acid. Among them, toluene is commonly used in the detection of urine and urine protein in medical tests; boric acid is commonly used in the inspection of protein, uric acid, 5-nodiacetic acid, proline, cortisol, estrogen, steroids, etc. in medical tests, and it can inhibit bacterial growth within 24 hours, so the above two preservatives are selected as the preservative components of urine samples. In addition, the water-soluble outer packaging bag containing the preservative in the utility model is made of polyvinyl alcohol, which is water-soluble and is a green and environmentally friendly packaging bag. When the sampled urine is poured into the antiseptic sampling tube 7, the preservative is completely soaked by the urine sample, and the water-soluble degradation of the packaging bag can be achieved within 5 minutes. At this time, the urine sample is fully in contact with the preservative to preserve the sample.
[0029] The above is only a preferred embodiment of the present invention. It should be pointed out that ordinary technicians in this technical field can make several improvements and supplements without departing from the principle of the present invention. These improvements and supplements should also be regarded as the protection scope of the present invention.
Claims
1. A urine proteomics DIA disease sampling and detection kit, characterized in that: The invention comprises a packaging box (1), a refrigerating chamber (2), a storage chamber (3), and a temperature display screen (4), wherein the temperature display screen (4) is arranged outside the packaging box (1), the refrigerating chamber (2) and the storage chamber (3) are arranged inside the packaging box (1), a temperature sensor (41) and a recorder (5) are arranged inside the temperature display screen (4), and the temperature sensor (41) is electrically connected to the recorder (5) on the inner side of the temperature display screen (4); the storage chamber (3) is arranged at the top of the packaging box (1) The storage chamber (3) contains the instruction manual of the DIA kit, a urine collection cup, a sealed bag, a non-additive sampling tube (6) and an antiseptic sampling tube (7); the bottom of the interior of the packaging box (1) is provided with the refrigerating chamber (2), the refrigerating chamber (2) is surrounded by a foam layer (8), a refrigerating tank (9) is embedded in the foam layer (8), the outer wall of the refrigerating tank (9) is provided with a heat-insulating coating (10), and the refrigerating tank (9) is embedded with ice bricks (11).
2. The urine proteomics DIA disease sampling and detection kit according to claim 1, characterized in that: The storage chamber (3) is located directly above the refrigeration tank (9), and the storage chamber (3) is embedded in the foam layer (8) until the top of the storage chamber (3) is flush with the top of the foam layer (8).
3. The urine proteomics DIA disease sampling and detection kit according to claim 1, characterized in that: The antiseptic sampling tube (7) is provided with a water-soluble bagged preservative (71), and the preservative is any one of toluene or boric acid.
4. The urine proteomics DIA disease sampling and detection kit according to claim 3, characterized in that: The water-soluble outer packaging bag of the preservative is made of polyvinyl alcohol.
5. The urine proteomics DIA disease sampling and detection kit according to claim 1, characterized in that: An inserting slot is fixed on the inner wall of the refrigerating tank (9), and an ice brick (11) and a sampling tube are embedded in the inserting slot.
6. The urine proteomics DIA disease sampling and detection kit according to claim 5, characterized in that: The ice brick (11) contains refrigeration liquid.
